SUBSCRIBE
SUBSCRIBE
News   Drug Development

France’s Ipsen Buys Biotech Firm Sterix

October 19, 2005 | 
1 min read
Private French drugmaker Ipsen said on Thursday it had acquired a small British biotechnology firm prior to a possible initial public offering, in the latest sign of a pick-up in activity in the European sector.
Clinical research Phase 1 IPO Mergers & acquisitions
MORE ON THIS TOPIC
IPO Initial Public Offering finance business concept. 3D render vector illustration of Trading on IPO Initial Public Offering, Business Startup and Stock Market Concept. Public offering share launch
IPO tracker
Generate’s IPO Could Reach $425M, Largest Raise Yet
February 24, 2026
 · 
5 min read
 · 
Tristan Manalac
Illustration of man walking in the beach between two blue seas, surreal abstract path concept
Rare disease
FDA’s Bespoke Pathway To Focus on Gene Editing and RNA-Based Treatments for Rare Diseases
February 23, 2026
 · 
3 min read
 · 
Nick Paul Taylor
Hand collage holding dollar paper money isolated on yellow background. Using cash to buy concept. Halftone effect in pop art style illustration.
Mergers & acquisitions
Gilead Doubles Down on CAR T With $7.8B Arcellx Acquisition
February 23, 2026
 · 
2 min read
 · 
Tristan Manalac
Concept of saving money with a pink colored piggy bank held in a hand in front of a blackboard with hand drawn coins
Weight loss
Novo’s CagriSema Falls to Lilly’s Zepbound in Daring Head-to-Head Test
February 23, 2026
 · 
4 min read
 · 
Annalee Armstrong